@article{fa08499d311f49efb5c26c57a23da05f,
title = "How does fingolimod (gilenya{\textregistered}) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?",
keywords = "Algorithm, Expert opinion, Fingolimod, Multiple sclerosis, Treatment",
author = "Franz Fazekas and Ovidiu Bajenaru and Thomas Berger and Fabjan, \{Tanja Hojs\} and Ledinek, \{Alenka Horvat\} and G{\'a}bor Jakab and Samuel Komoly and Tetiana Kobys and J{\"o}rg Kraus and Egon Kur{\v c}a and Theodoros Kyriakides and L'ubom{\'i}r Lis{\'y} and Ivan Milanov and Tetyana Nehrych and Sergii Moskovko and Panayiotis Panayiotou and Jazbec, \{Sa{\v s}a {\v S}ega\} and Larysa Sokolova and Radom{\'i}r Tal{\'a}b and Latchezar Traykov and Peter Tur{\v c}{\'a}ni and Karl Vass and Norbert Vella and Nataliya Voloshyn{\'a} and Eva Havrdov{\'a}",
year = "2013",
doi = "10.3389/fneur.2013.00010",
language = "English",
volume = "4 MAY",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Media SA",
}